These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30225530)
1. Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome. Sasaki R; Horimoto Y; Mizuno J; Edahiro Y; Ohmori T; Komatsu N; Saito M Surg Case Rep; 2018 Sep; 4(1):118. PubMed ID: 30225530 [TBL] [Abstract][Full Text] [Related]
2. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor. Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961 [TBL] [Abstract][Full Text] [Related]
3. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys. Federici AB Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome. Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586 [TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Federici AB Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report. Baldeo CM; Rivera CE; Tun HW; Vishnu P J Blood Med; 2018; 9():9-13. PubMed ID: 29403324 [TBL] [Abstract][Full Text] [Related]
7. Treatment of von Willebrand Disease. Curnow J; Pasalic L; Favaloro EJ Semin Thromb Hemost; 2016 Mar; 42(2):133-46. PubMed ID: 26838696 [TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndrome--report of 10 cases and review of the literature. Nitu-Whalley IC; Lee CA Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513 [TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [TBL] [Abstract][Full Text] [Related]
10. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera. Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526 [TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Federici AB Semin Thromb Hemost; 2011 Feb; 37(1):35-40. PubMed ID: 21305800 [TBL] [Abstract][Full Text] [Related]
12. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD). Mohammed S; Favaloro EJ Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome: data from an international registry. Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE; Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711 [TBL] [Abstract][Full Text] [Related]
14. Analysis of current perioperative management with Haemate Hazendonk HCAM; Heijdra JM; de Jager NCB; Veerman HC; Boender J; van Moort I; Mathôt RAA; Meijer K; Laros-van Gorkom BAP; Eikenboom J; Fijnvandraat K; Leebeek FWG; Cnossen MH; Haemophilia; 2018 May; 24(3):460-470. PubMed ID: 29573506 [TBL] [Abstract][Full Text] [Related]
15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3. Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493 [TBL] [Abstract][Full Text] [Related]
16. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568 [TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside. Federici AB; Budde U; Rand JH Hamostaseologie; 2004 Feb; 24(1):50-5. PubMed ID: 15029273 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of acquired von Willebrand syndrome. Tiede A Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003 [TBL] [Abstract][Full Text] [Related]
19. Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease. Mannucci PM; Franchini M Haemophilia; 2017 Mar; 23(2):182-187. PubMed ID: 28111840 [TBL] [Abstract][Full Text] [Related]
20. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P). Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]